Market overview
The global rubber stopper market is worth USD 1.6 bn in 2026 and is forecast to reach USD 2.9 bn by 2036, growing at a 6.3% CAGR. United States is the largest country market and Bromobutyl is the largest by material segment.
| Scope | Elastomer stoppers that seal pharmaceutical vials, infusion bottles and lyophilised drug containers, in bromobutyl and chlorobutyl rubber, coated and uncoated. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.5 bn |
| Value 2026 | USD 1.6 bn |
| Value 2036 | USD 2.9 bn |
| CAGR 2026-2036 | 6.3% |
| Volume 2026 | 55,886 million pieces |
| Volume 2036 | 93,202 million pieces |
| Average price 2026 | USD 0.03 per piece |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Rubber Stopper market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.6 bn |
| 2027 | USD 1.7 bn |
| 2028 | USD 1.8 bn |
| 2029 | USD 1.9 bn |
| 2030 | USD 2.0 bn |
| 2031 | USD 2.2 bn |
| 2032 | USD 2.3 bn |
| 2033 | USD 2.5 bn |
| 2034 | USD 2.6 bn |
| 2035 | USD 2.8 bn |
| 2036 | USD 2.9 bn |
Rubber Stopper market segmentation
By material
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Bromobutyl | 44.0% | 44.1% | USD 703 mn | 6.3% |
| Chlorobutyl | 30.0% | 28.7% | USD 479 mn | 5.8% |
| Others (butyl, silicone, synthetic) | 26.0% | 27.3% | USD 415 mn | 6.8% |
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Coated and laminated stoppers | 48.0% | 55.7% | USD 767 mn | 7.9% |
| Uncoated stoppers | 34.0% | 27.0% | USD 543 mn | 3.9% |
| Lyophilisation and infusion stoppers | 18.0% | 17.3% | USD 288 mn | 5.9% |
By end use
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Injectable drugs | 52.0% | 49.3% | USD 831 mn | 5.7% |
| Biologics and vaccines | 28.0% | 33.5% | USD 447 mn | 8.2% |
| Diagnostics and others | 20.0% | 17.2% | USD 320 mn | 4.7% |
By closure
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vial stoppers | 56.0% | 56.0% | USD 895 mn | 6.3% |
| Infusion bag ports | 16.0% | 14.0% | USD 256 mn | 4.9% |
| Syringe plungers and tip caps | 16.0% | 18.0% | USD 256 mn | 7.6% |
| Cartridge and other | 12.0% | 12.0% | USD 192 mn | 6.3% |
By coating
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fluoropolymer film | 38.0% | 42.0% | USD 607 mn | 7.4% |
| Silicone coated | 24.0% | 22.0% | USD 383 mn | 5.4% |
| Uncoated | 38.0% | 36.0% | USD 607 mn | 5.7% |
Top 25 countries for rubber stopper by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.0% of 2026 revenue and the 25 countries below together hold 94.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 367 mn | 23.0% | USD 639 mn | 5.7% |
| 2 | China | USD 320 mn | 20.0% | USD 668 mn | 7.7% |
| 3 | Germany | USD 128 mn | 8.0% | USD 212 mn | 5.2% |
| 4 | India | USD 128 mn | 8.0% | USD 294 mn | 8.7% |
| 5 | Japan | USD 96 mn | 6.0% | USD 144 mn | 4.2% |
| 6 | France | USD 72 mn | 4.5% | USD 118 mn | 5.1% |
| 7 | Italy | USD 64 mn | 4.0% | USD 106 mn | 5.2% |
| 8 | United Kingdom | USD 56 mn | 3.5% | USD 91 mn | 5.0% |
| 9 | Brazil | USD 48 mn | 3.0% | USD 91 mn | 6.7% |
| 10 | South Korea | USD 48 mn | 3.0% | USD 91 mn | 6.7% |
| 11 | Mexico | USD 42 mn | 2.6% | USD 86 mn | 7.3% |
| 12 | Switzerland | USD 25 mn | 1.6% | USD 40 mn | 4.7% |
| 13 | Spain | USD 19 mn | 1.2% | USD 29 mn | 4.7% |
| 14 | Canada | USD 15 mn | 0.9% | USD 24 mn | 4.7% |
| 15 | Belgium | USD 13 mn | 0.8% | USD 20 mn | 4.7% |
| 16 | Netherlands | USD 11 mn | 0.7% | USD 17 mn | 4.7% |
| 17 | Indonesia | USD 9.9 mn | 0.6% | USD 22 mn | 8.3% |
| 18 | Turkey | USD 8.9 mn | 0.6% | USD 20 mn | 8.4% |
| 19 | Russia | USD 8.2 mn | 0.5% | USD 13 mn | 4.7% |
| 20 | Poland | USD 7.5 mn | 0.5% | USD 17 mn | 8.6% |
| 21 | Australia | USD 7.0 mn | 0.4% | USD 11 mn | 4.8% |
| 22 | Thailand | USD 6.5 mn | 0.4% | USD 15 mn | 8.4% |
| 23 | Argentina | USD 6.2 mn | 0.4% | USD 14 mn | 8.3% |
| 24 | Austria | USD 5.9 mn | 0.4% | USD 9.1 mn | 4.4% |
| 25 | Saudi Arabia | USD 5.6 mn | 0.3% | USD 12 mn | 8.3% |
| Rest of world | USD 81 mn | 5.1% | USD 139 mn | 5.5% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- West Pharmaceutical Services
- Datwyler
- Aptar
- Nipro
Group 2: Regional and specialist players
- Daikyo Seiko
- Stevanato Group
- Helvoet Pharma
- Taisei Kako
- Pharma-Gummi Wimmer
- Stelmi
Group 3: Emerging and niche players
- Jiangsu Hualan New Pharmaceutical Material
- Shandong Pharmaceutical Glass
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the rubber stopper market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.3% is calculated from the resulting values.
The market is divided by material, by type, by end use, by closure, by coating. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the rubber stopper market?
The global rubber stopper market is estimated at USD 1.5 bn in 2025 and USD 1.6 bn in 2026.
How fast will the rubber stopper market grow?
It is forecast to reach USD 2.9 bn by 2036, a compound annual growth rate of 6.3% from 2026, an increase of USD 1.3 bn.
Which country is the largest market for rubber stopper?
United States is the largest market by revenue at USD 367 mn in 2026, 23.0% of the global total. The three largest countries together hold 51.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 8.7% a year from 2026 to 2036.
Which rubber stopper segment is largest?
In the by material split, Bromobutyl is the largest segment with 44.0% of 2026 revenue.
Who are the leading rubber stopper companies?
Global leaders include West Pharmaceutical Services, Datwyler, Aptar, Nipro.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Animal Wound CareUSD 1.6 bn · 7.0% CAGR
- Microplate ReaderUSD 1.7 bn · 6.5% CAGR
- NebulizerUSD 1.5 bn · 6.0% CAGR
- Mechanical Thrombectomy SystemUSD 1.7 bn · 10.0% CAGR
- CentrifugeUSD 1.7 bn · 6.0% CAGR
- Animal Immunoassay KitsUSD 1.5 bn · 7.0% CAGR
- Vascular Thromboembolic Disease ThrombectomyUSD 1.5 bn · 13.0% CAGR
- CartridgeUSD 1.7 bn · 7.2% CAGR